On November 13th EyeOn hosted an idealab on the impact of MDR (=Medical Device Regulation) on supply chain planning processes in Brussels.

After a brief clarification on the new EU MDR regulations and an introduction on the planning impact, participants discussed the elements to consider from a supply planning perspective.

Regulatory aspects, timing of registrations, portfolio review, integration of MDR changes in the S&OP cycle, master data management, demand and supply risks were some of the topics that were considered as points of attention for a proper supply chain integration of MDR regulations.

Participants confirmed the impact of MDR on supply chain planning is severely underestimated and emphasized MDR is more than a QA/RA topic.

MDR really needs to be addressed cross departmental with senior management attention on systematic risk review.

Please find a selection of slides here.

For more information about MDR and its impact on planning you can contact Vasco Werners, Luc van Wouwe, or Loek Lemmens.